IDN-5109:: A novel, orally active, semisynthetic taxane which modulates P-glycoprotein and overcomes P-glycoprotein mediated multi-drug resistance in human colon and breast carcinomas in vitro and in vivo.

被引：0
|
作者：
Vredenburg, MR
Ojima, I
Veith, J
Pera, P
Kee, K
Cabral, FR
Sharma, A
Kanter, P
Bernacki, RJ
机构：
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
[2] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[3] Univ Texas, Sch Med, Houston, TX USA
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
554
引用
收藏
页码：4577S / 4577S
页数：1
相关论文
共 32 条
  • [31] In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-glycoprotein and Breast Cancer Resistance Protein: Part II. The Impact of Cross-Laboratory Variations of Intestinal Transporter Relative Expression Factors on Predicted Drug Disposition
    Harwood, Matthew D.
    Achour, Brahim
    Neuhoff, Sibylle
    Russell, Matthew R.
    Carlson, Gordon
    Warhurst, Geoffrey
    Rostami-Hodjegan, Amin
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (03) : 476 - 480
  • [32] In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-Glycoprotein and Breast Cancer Resistance Protein: Part I: A Cross-Laboratory Comparison of Transporter-Protein Abundances and Relative Expression Factors in Human Intestine and Caco-2 Cells
    Harwood, Matthew D.
    Achour, Brahim
    Neuhoff, Sibylle
    Russell, Matthew R.
    Carlson, Gordon
    Warhurst, Geoffrey
    Rostami-Hodjegan, Amin
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (03) : 297 - 307
1234